Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOT VAC | VAC | 3.27% |
| BLOOMIN BRAN | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We are downgrading our recommendation on Iconix Brand Group, Inc. (ICON - Analyst Report) to Underperform from Neutral, following the disappointing first quarter 2012 results.
Iconix posted lower-than-expected first quarter 2012 adjusted earnings of 43 cents per shar; 6.5% lower than the Zacks Consensus Estimate and down 4.4% from the prior year earnings period. The weak results were driven chiefly by revenue declines, primarily due to continued weaknesses in men’s brands of Rocawear, Ecko and Ed Hardy. Total revenue in the quarter declined 4.0% to $88.5 million. Revenue also missed the Zacks Consensus Estimate of $95 million. The soft revenues were also brought about by the transition of the company’s Royal Velvet brand to J. C. Penny Company, Inc. (JCP - Analyst Report), which is expected to impact Iconix in the near term.
Slow demand in the men’s brands of Rocawear, Ecko and Ed Hardy and the transfer of Royal Velvet brand also resulted in the full-year 2012 guidance cut for revenues to $340-$350 million from $370-$385 million. Iconix also slashed its 2012 guidance for earnings to a range of $1.65 - $1.74 per share from $1.77 - $1.84 per share.
Although the company remains positive over the long term with its strong brand portfolio and its continuous efforts to expand in the emerging markets, we expect some near-term challenges for the company. Iconix is currently experiencing a significant slowdown in customer traffic, which has affected its revenues and margins. The overall macroeconomic uncertainty and increased unemployment levels have negatively affected the level of consumer spending for discretionary items. In addition, Iconix remains exposed to unfavorable foreign currency translations and faces severe competition for its brands from various domestic and foreign brands. We, thus, lowered our rating to Underperform from Neutral.
Read the full reports :
Analyst Report on JCP
Analyst Report on ICON